STAT Digital Event Series: Combating Covid-19

Actions and Detail Panel

Sales Ended

Event Information

Share this event

Date and Time

Location

Location

Online Event

Event description
Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19.

About this Event

About:

The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or vaccines can be developed.

Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments, who will come prepared to answer tough questions. They’ll discuss current findings, clinical trials, and efforts to expedite approvals as we face this global pandemic.

This series will take place on Zoom, an interactive platform where attendees will be able to not only see the discussions live, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website.

Schedule: Please note, dates and times are subject to change as the story evolves.

Part 1: Antibody drugs that target the coronavirus. April 8 at 1 p.m EST

  • Sponsor Introduction: Stephen J. Ubl, president and chief executive officer, PhRMA
  • George Yancopoulos, co-founder, president and chief scientific officer, Regeneron
  • Matt Herper, senior writer, medicine, and editorial director of events, STAT

You can watch the recorded conversation with George Yancopoulos here.

Part 2: Fighting on multiple fronts. April 29 at 1 p.m. EST

  • Sponsor Introduction: Richard Moscicki, M.D., chief medical officer and executive vice president of Science and Regulatory Advocacy, PhRMA
  • Mikael Dolsten, M.D., Ph.D., chief scientific officer, Pfizer
  • Matt Herper, senior writer, medicine, and editorial director of events, STAT

You can watch the recorded conversation with Mikael Dolsten here.

Part 3: Vaccines — can they come soon enough? May 6 at 1 p.m EST

  • Sponsor Introduction: Clem Lewin, Ph.D., associate vice president of R&D strategy for vaccines, Sanofi
  • Tal Zaks, chief medical officer, Moderna
  • Matt Herper, senior writer, medicine, and editorial director of events, STAT

You can watch the recorded conversation with Tal Zaks here.

Sponsored by:


		STAT Digital Event Series: Combating Covid-19 image

Date and Time

Location

Online Event

Save This Event

Event Saved